Genotypic testing for human immunodeficiency virus type 1 drug resistance.

doi:10.1128/CMR.15.2.247-277.2002

Back to search

Article

Genotypic testing for human immunodeficiency virus type 1 drug resistance.

Clinical microbiology reviews - 1 Apr 2002

Shafer Robert W

Abstract excerpt

There are 16 approved human immunodeficiency virus type 1 (HIV-1) drugs belonging to three mechanistic classes: protease inhibitors, nucleoside and nucleotide reverse transcriptase (RT) inhibitors, and nonnucleoside RT inhibitors. HIV-1 resistance to these drugs is caused by mutations in the prot...

Topics

Anti-HIV Agents
Drug Resistance, Viral
Drug Therapy, Combination
Genotype
HIV Infections
HIV Protease
HIV Reverse Transcriptase
HIV-1
Humans
Microbial Sensitivity Tests
Reverse Transcriptase Inhibitors

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.